For the year ending 2025-12-31, PASG has $62,281K in assets. $43,526K in debts. $46,303K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 46,303 | |||
| Prepaid expenses and other current assets | 629 | |||
| Prepaid research and development | 830 | |||
| Total current assets | 47,762 | |||
| Property and equipment, net | 4,107 | |||
| Right of use assets - operating leases | 10,168 | |||
| Other assets | 244 | |||
| Total assets | 62,281 | |||
| Accounts payable | 1,113 | |||
| Accrued expenses and other current liabilities | 4,653 | |||
| Non-refundable sublicense and transition services payments | 13,750 | |||
| Operating lease liabilities | 3,567 | |||
| Total current liabilities | 23,083 | |||
| Operating lease liabilities - noncurrent | 20,443 | |||
| Total liabilities | 43,526 | |||
| Additional paidin capital | 723,512 | |||
| Accumulated deficit | -704,757 | |||
| Total stockholders' equity | 18,755 | |||
| Total liabilities and stockholders' equity | 62,281 | |||
Passage BIO, Inc. (PASG)
Passage BIO, Inc. (PASG)